Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) FCF Margin (2020 - 2025)

Bioventus (BVS) has disclosed FCF Margin for 6 consecutive years, with 23.68% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 1085.0% year-over-year to 23.68%, compared with a TTM value of 12.69% through Dec 2025, up 593.0%, and an annual FY2025 reading of 12.69%, up 593.0% over the prior year.
  • FCF Margin was 23.68% for Q4 2025 at Bioventus, up from 21.37% in the prior quarter.
  • Across five years, FCF Margin topped out at 23.68% in Q4 2025 and bottomed at 23.74% in Q2 2021.
  • Average FCF Margin over 5 years is 4.05%, with a median of 7.61% recorded in 2021.
  • The sharpest move saw FCF Margin plummeted -4585bps in 2021, then skyrocketed 2137bps in 2023.
  • Year by year, FCF Margin stood at 13.03% in 2021, then fell by -29bps to 9.28% in 2022, then crashed by -35bps to 6.05% in 2023, then soared by 112bps to 12.83% in 2024, then surged by 85bps to 23.68% in 2025.
  • Business Quant data shows FCF Margin for BVS at 23.68% in Q4 2025, 21.37% in Q3 2025, and 17.1% in Q2 2025.